Search
Patexia Research
Case number 2:22-cv-02952

CELGENE CORPORATION v. ONCOGEN PHARMA (MALAYSIA) SDN. BHD. > Documents

Date Field Doc. No.Description (Pages)
May 25, 2022 6 Order of Dismissal (4)
Docket Text: CONSENT JUDGMENT that all claims, counterclaims, affirmative defenses and demands in this action that relate to Oncogen are hereby dismissed with prejudice and without costs, disbursements, or attorneys fees to any party; etc. Signed by Judge Susan D. Wigenton on 5/25/2022. (sm)
May 24, 2022 5 Letter (5)
Docket Text: Letter from Celgene to the Hon. Susan D. Wigenton, U.S.D.J.. (LIZZA, CHARLES)
May 23, 2022 3 Summons Issued (2)
Docket Text: SUMMONS ISSUED as to ONCOGEN PHARMA (MALAYSIA) SDN. BHD.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (lag, )
May 23, 2022 4 Main Document (1)
Docket Text: AO120 Patent Form filed. (Attachments: # (1) Complaint) (lag, )
May 23, 2022 4 Complaint (20)
May 20, 2022 N/A Case Assigned/Reassigned (0)
Docket Text: Case assigned to Judge Susan D. Wigenton and Magistrate Judge Leda D. Wettre. (jr)
May 20, 2022 1 Main Document (20)
Docket Text: COMPLAINT against ONCOGEN PHARMA (MALAYSIA) SDN. BHD. ( Filing and Admin fee $ 402 receipt number ANJDC-13425643) , Related Case Selected, filed by CELGENE CORPORATION. (Attachments: # (1) Exhibits A-D, # (2) Exhibits E-G, # (3) Civil Cover Sheet)(LIZZA, CHARLES)
May 20, 2022 1 Exhibits A-D (217)
May 20, 2022 1 Exhibits E-G (92)
May 20, 2022 1 Civil Cover Sheet (1)
May 20, 2022 2 Corporate Disclosure Statement (aty) (2)
Docket Text: Corporate Disclosure Statement by CELGENE CORPORATION. (LIZZA, CHARLES)
May 20, 2022 1 Complaint* (1)
Menu